GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medx Health Corp (OTCPK:MDXHF) » Definitions » Debt-to-Asset

MDXHF (Medx Health) Debt-to-Asset : 8.37 (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medx Health Debt-to-Asset?

Medx Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $4.68 Mil. Medx Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.74 Mil. Medx Health's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was $0.65 Mil. Medx Health's debt to asset for the quarter that ended in Sep. 2024 was 8.37.


Medx Health Debt-to-Asset Historical Data

The historical data trend for Medx Health's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medx Health Debt-to-Asset Chart

Medx Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.79 1.29 3.53 6.96 8.48

Medx Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.63 8.48 8.97 7.78 8.37

Competitive Comparison of Medx Health's Debt-to-Asset

For the Medical Devices subindustry, Medx Health's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medx Health's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Medx Health's Debt-to-Asset falls into.



Medx Health Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Medx Health's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Medx Health's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medx Health  (OTCPK:MDXHF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Medx Health Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Medx Health's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Medx Health Business Description

Traded in Other Exchanges
Address
1495 Bonhill Road, Unit 1, Mississauga, ON, CAN, L5T 1M2
Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.